Found 26 matching trials
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) PHASE1 This is an open-label, single center, non-randomized, phase Ⅱ trial to eval...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC) PHASE2 This single arm, open label, single center, prospective study was designed ...
Show More Location
Beijing Union Medical College Hospital
Learn More & Join Trial
Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II,Multi-center, Clinical Study. PHASE1 The survival rate of recurrent and refractory pediatric neuroblastoma is lo...
Show More Learn More & Join Trial
Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma PHASE2 Esophageal cancer is a common malignant disease worldwide especially in chi...
Show More Location
Beijing Cancer Hospital / Peking University Cancer Hospital
Learn More & Join Trial
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression PHASE3 This is a Phase III, randomized, multicenter, open-label clinical trial des...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer PHASE2 This study aims to evaluate the efficacy and safety of a combination treatm...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Chemotherapy Combined With Apatinib and PD-1 Antibody PHASE2 The effective rate of second-line and later-line single-agent therapy for a...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer PHASE2 Patients with previously untreated advanced or metastatic esophageal squamo...
Show More Learn More & Join Trial
Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors PHASE2 An exploratory study to evaluate for the treatment of advanced solid tumors...
Show More Location
Nanjing Drum Tower Hospital, The Affiliated of Nanjing University Medical School
Learn More & Join Trial
Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma PHASE1 The study is aimed to evaluate the efficacy and safety of Apatinib and Irin...
Show More Location
The First's People Hospital of Lianyungang
Learn More & Join Trial